Locations:

Tag: checkpoint inhibitor therapy

August 28, 2024/Cancer/Research

Case Study: Patient with Metastatic Urothelial Carcinoma Has No Remaining Evidence of Disease

Treatment involved checkpoint inhibitor, surgery and intravesical therapy

December 4, 2023/Cancer

First of Its Kind: Oncology Pharmacovigilance Clinic

Multidisciplinary care for patients with immune-related adverse events

August 10, 2023/Diabetes & Endocrinology/Research

Endocrinopathies from Checkpoint Inhibitors

Incidence, outcomes and management

January 16, 2023/Cancer/Research

ASCO Releases New Guidelines for Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers

Recommendations focus on selecting the right biomarkers for the right setting

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

November 23, 2020/Cancer/Tumor Oncology

Case Report: Immunotherapy + Vaccine Helps 62-Year-Old with Colorectal Cancer

Nivolumab, CV301 and systemic chemotherapy trial

October 8, 2020/Cancer/Tumor Oncology

FDA Approves New Treatment Regime for Advanced Liver Cancer

IMbrave-150 changes standard of care

December 20, 2019/Rheumatology & Immunology/Rheumatic Diseases

Polymyalgia Rheumatica-Like Syndrome from Checkpoint Inhibitor Therapy

Same old disease or something different?

August 27, 2019/Rheumatology & Immunology/News & Insights

Rheumatic Immune-Related Adverse Events from Checkpoint Inhibitor Therapy: Update

irAEs are a formidable challenge

18-RHE-10377-Calabrese-Hero-Image-650x450pxl

January 22, 2019/Cancer

A Novel Tumor Board for Patients with Immune-Related Adverse Events

Collaborating to treat this emerging complication of CPI

January 25, 2018/Rheumatology & Immunology/News & Insights

Checkpoint Inhibitor Therapy for Patients with Immune-Mediated Inflammatory Diseases (Video)

Dr. Leonard Calabrese outlines a complex topic

BackPage 1 of 1Next